Global Vaccine for Swine Fever Market Size, Share & Trends Analysis Report, By Drug (Trivalent, Quadrivalent, and Recombinant Bivalent), By Application (Government Tender and Market Sales), Forecast (2022-2028)

The global vaccine for swine fever market is anticipated to grow at a significant CAGR 5% during the forecast period (2022-2028). Swine fever is generally defined as a highly contagious and deadly viral disease that affects both domestic and feral swine of all ages. This vaccine supports in the prevention of contagious swine fever among pigs, through passive and active immunity as a method of disease protection. The market is likely to substantially grow majorly due to the contributions of government as well as non-government organizations toward research studies as well as novel launches. For instance, in May 2020, Indian Immunological, announced the launch of the classical swine fever (CSF) vaccine under the brand name ‘Raksha Class’.

Porcine echovirus (PTV) is a non-enveloped RNA virus belonging to the genus Teschovirus and the family Picornaviridae, according to the Swine Health Information Center (SWIC). Thus, in order to prevent the swine herds from such contagious diseases, their vaccine market is anticipated to grow during the forecast period. Furthermore, technological advancements in the field of medicine, such as genetically engineered vaccines, are contributing to the market growth. Moreover, the surge in the demand for the vaccine is another factor imposing a positive outlook on the market. Different regulations and policies of different countries govern the approval and authorization of animal vaccinations. For instance, the Center for Veterinary Biologics (CVB) of the USDA’s Animal and Plant Health Inspection Service (APHIS) regulates vaccine production and marketing in the US.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-

• By Drug
• By Application

• Regions covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape: Zoetis Inc., Merck & Co., Inc., and Elanco Animal Health Inc., among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

• Deviation from the pre-COVID-19 forecast
• Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Vaccine for Swine Fever Market Report by Segment

By Drug

• Trivalent
• Quadrivalent
• Recombinant Bivalent

By Application

• Government Tender
• Market Sales

Global Vaccine for Swine Fever Market Report by Region

North America

• US
• Canada

Europe

• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East and Africa